Federal Register / Vol. 61, No. 85 / Wednesday, May 1, 1996 / Notices 19295

Wetlands means those areas that are

inundated or saturated by surface or

ground water at a frequency and

duration sufficient to support, and that

under normal circumstances do support,

a prevalence of vegetation typically

adapted for life in saturated soil

conditions. Wetlands generally include

swamps, marshes, bogs, and similar

areas.

2. Abbreviations when used in this

permit are defined below:

cu. M/day or M3/day—cubic meters per

day

mg/l—milligrams per liter

ug/l—micrograms per liter

lbs/day—pounds per day

kg/day—kilograms per day

Temp. °C—temperature in degrees

Centigrade

Temp. °F—temperature in degrees

Fahrenheit

Turb.—turbidity measured by the

Nephelometric Method (NTU)

pH—a measure of the hydrogen ion

concentration

CFS—cubic feet per second

MGD—million gallons per day

Oil & Grease—Freon extractable

material

ml/l—milliliter(s) per liter

Cl2—total residual chlorine

[FR Doc. 96–10813 Filed 4–30–96; 8:45 am]

BILLING CODE 6560–50–P

FEDERAL COMMUNICATIONS

COMMISSION

[Report No. 2128]

Petitions for Reconsideration,

Clarification and Stay of Actions in

Rulemaking Proceedings

April 17, 1996.

Petitions for reconsideration,

clarification and stay have been filed in

the Commission rulemaking

proceedings listed in this Public Notice

and published pursuant to 47 CFR

Section 1.429(e). The full text of these

documents are available fore viewing

and copying in Room 239, 1919 M

Street, N.W., Washington, D.C. or may

be purchased from the Commission’s

copy contractor ITS, Inc. (202) 857–

3800. Opposition to this petition must

be filed May 7, 1996. See Section

1.4(b)(1) of the Commission’s rules (47

CFR 1.4(b)(1)). Replies to an opposition

must be filed within 10 days after the

time for filing oppositions has expired.

Subject: Petition for Declaratory Ruling

by the Inmate Calling Services

Providers Task Force (RM–8181).

Number of Petitions Filed: 2.

Subject: Amendment of Section

73.202(b), Table of Allotments, FM

Broadcast Stations. (Farmington,

Grass Valley, Jackson Linden,

Placerville and Fair Oaks, California

and Carson City and Sun Valley,

Nevada) (MM Docket No. 90–189,

RM–6904, RM–7114, RM–7186, RM–

7415, RM–7298). Number of Petitions

Filed: 1.

Subject: Implementation of Sections of

the Cable Television Consumer

Protection and Competition Act of

1992—Rate Regulation (MM Docket

No. 93–215). Adoption of a Uniform

Accounting System for Provision of

Regulated Cable Service (CS Docket

No. 94–28). Number of Petitions

Filed: 2.

Subject: Amendment of the

Commission’s Rules to Establish

Rules and Policies Pertaining to a

Mobile Satellite Service in the 1610—

1626.5/2483.5—2500 MHz Frequency

Band (CC Docket No. 92–166).

Number of Petitions Filed: 3.

Subject: Streamlining the Commission’s

Antenna Structure Clearance and

Revision of Part 17 of the

Commission’s Rules Concerning

Construction, Marking, and Lighting

of Antenna Structures (WT Docket

No. 95–5). Number of Petitions Filed:

2.

Subject: Toll Free Service Access Codes

(CC Docket No. 95–155). Number of

Petitions Filed: 1.

Federal Communications Commission.

William F. Caton,

Acting Secretary.

[FR Doc. 96–9746 Filed 4–30–96; 8:45 am]

BILLING CODE 6712–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

SUMMARY: Notice is hereby given that

the Office of Research Integrity (ORI)

has made final findings of scientific

misconduct in the following case:

Andrew Friedman, M.D., Harvard

Medical School

Based on a report from Harvard

Medical School and Dr. Friedman’s

admission, ORI found that Andrew

Friedman, M.D., former Harvard

Medical School Associate Professor of

Obstetrics, Gynecology, and

Reproductive Biology at the Brigham

and Women’s Hospital, committed

scientific misconduct by falsifying and

fabricating data in research supported in

part by a Public Health Service (PHS)

grant to the Brigham and Women’s

Hospital General Clinical Research

Center.

Between 1992 and 1995, Dr. Friedman

altered and fabricated information in

permanent patient medical records and

notes by changing dates, changing and

adding text, and fabricating notes for

clinical visits that did not occur. Dr.

Friedman admitted that he had falsified

and fabricated approximately 80 percent

of the data in research reports published

in Fertility and Sterility (Friedman, A.J.

and Thomas, P.P. ‘‘Gonadotrophinreleasing hormone agonist plus

estrogen-progestin ‘add-back’ therapy

for endometriosis-related pelvic pain.’’

Fertility and Sterility 30:236–41, 1993.),

in Obstetrics and Gynecology

(Friedman, A.J. and Thomas P.P. ‘‘Does

low-dose combination oral

contraceptive use affect uterine size or

menstrual flow in premenopausal

women with leiomyomas?’’ Obstetrics

and Gynecology, pp. 631–635, 1995.),

and in an unpublished manuscript.

Dr. Friedman has entered into a

Voluntary Exclusion Agreement with

ORI in which he has voluntarily agreed:

(1) To exclude himself from any

contracting or subcontracting with any

agency of the United States Government

and from eligibility for, or involvement

in, nonprocurement transactions (e.g.,

grants and cooperative agreements) of

the United States Government, as

defined in 45 C.F.R. Part 76 and 48

C.F.R. Subparts 9.4 and 309.4

(Debarment Regulations) for a period of

three (3) years beginning April 19, 1996;

(2) That for a period of two (2) years

immediately following the three (3) year

voluntary exclusion above, any

institution that submits an application

for PHS support for a research project

on which Dr. Friedman’s participation

is proposed or that uses him in any

capacity on PHS supported research

must concurrently submit a plan for

supervision of his duties; the

supervisory plan must be designed to

ensure the scientific integrity of Dr.

Friedman’s research contribution, and

the institution must submit a copy of

the plan to ORI; and

(3) To exclude himself from serving in

any advisory capacity to PHS, including

but not limited to service on any PHS

advisory committee, board, and/or peer

review committee, or as a consultant for

a period of three (3) years beginning

April 19, 1996.

The voluntary exclusion in (1) above

shall not apply to Dr. Friedman’s future

training or practice of clinical medicine

whether as a medical student, resident,

fellow, or licensed practitioner, as the
19296 Federal Register / Vol. 61, No. 85 / Wednesday, May 1, 1996 / Notices

case may be, unless that practice

involves research or research training.

A statement retracting the article

entitled ‘‘Gonadotrophin-releasing

hormone agonist plus estrogen-progestin

‘add-back’ therapy for endometriosisrelated pelvic pain.’’ (Fertility and

Sterility 30:236–41, 1993) has been

published in Fertility and Sterility

(65(1):211, January 1996), and a

statement retracting the article entitled

‘‘Does low-dose combination oral

contraceptive use affect uterine size or

menstrual flow in premenopausal

women with leiomyomas?’’ (Obstetrics

and Gynecology, pp. 631–635, 1995) has

been published in Obstetrics and

Gynecology (85(5):728, November 1995).

FOR FURTHER INFORMATION CONTACT:

Director, Division of Research

Investigations, Office of Research

Integrity, 5515 Security Lane, Suite 700,

Rockville, MD 20852.

Chris B. Pascal,

Acting Director, Office of Research Integrity.

[FR Doc. 96–10731 Filed 4–30–96; 8:45 am]

BILLING CODE 4160–17–P

Centers for Disease Control and

Prevention and Agency for Toxic

Substances and Disease Registry

[Announcement 703]

Public Health Conference Support

Grant Program

Introduction

The Centers for Disease Control and

Prevention (CDC) and the Agency for

Toxic Substances and Disease Registry

(ATSDR) announce the availability of

funds in fiscal year (FY) 1997 for the

Public Health Conference Support Grant

Program. CDC and ATSDR are

committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2000,’’ a

national activity to reduce morbidity

and mortality and improve the quality

of life. This announcement is related to

all of the Healthy People 2000 priority

areas, except HIV Infection. (An

announcement for HIV entitled, ‘‘Public

Health Conference Support Cooperative

Agreement Program for Human

Immunodeficiency Virus (HIV)

Prevention’’ will be published.) (For

ordering a copy of ‘‘Healthy People

2000,’’ see the Section ‘‘Where To

Obtain Additional Information.’’)

Authority

The CDC program is authorized under

Section 301 [42 U.S.C. 241] and Section

310 [42 U.S.C. 242n] of the Public

Health Service Act. The ATSDR

program is authorized under Sections

104(i)(14) and (15) of the

Comprehensive Environmental

Response, Compensation, and Liability

Act (CERCLA) of 1980, as amended, [42

U.S.C. 9604 (i)(14) and (15)].

Smoke-Free Workplace

CDC and ATSDR strongly encourage

all grant recipients to provide a smokefree workplace and promote the non-use

of all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

CDC eligible applicants include

public and private (e.g., communitybased, national and regional)

organizations, nonprofit and for-profit

organizations and governments and

their agencies. Thus, universities,

colleges, research institutions, hospitals,

other public and private organizations,

State and local governments or their

bona fide agents, federally recognized

Indian tribal governments, Indian tribes

or Indian tribal organizations, and

small, minority and/or women-owned

businesses are eligible for these grants.

ATSDR eligible applicants are the

official public health agencies of the

States, or their bona fide agents. This

includes the District of Columbia,

American Samoa, the Commonwealth of

Puerto Rico, the Virgin Islands, the

Federated States of Micronesia, Guam,

the Northern Mariana Islands, the

Republic of the Marshall Island, the

Republic of Palau, and federally

recognized Indian tribal governments.

State organizations, including State

universities, State colleges, and State

research institutions, must establish that

they meet their respective State’s

legislature definition of a State entity or

political subdivision to be considered

an eligible applicant.

Availability of Funds

Approximately $500,000 from CDC is

expected to be available in FY 1997 to

fund approximately 25–30 awards. The

awards range from $1,000 to $30,000

with the average award being

approximately $15,000. The awards will

be made for a 12-month budget and

project period. The funding estimates

may vary and are subject to change,

based on the availability of funds.

ATSDR expects to have approximately

$50,000 available in FY 1997 to fund

approximately 6 awards. It is expected

that the average award will be $8,000,

ranging from $5,000 to $10,000.

Applications requesting more than

$10,000 will be given a lesser priority

and will be subject to the availability of

funds. The awards will be made for a

12-month budget and project period.

Funding estimates may vary and are

subject to change.

Use of Funds

• CDC and ATSDR funds may be used

for direct cost expenditures: salaries,

speaker fees, rental of necessary

equipment, registration fees, and

transportation costs (not to exceed

economy class fare) for non-Federal

employees.

• CDC and ATSDR funds may NOT

be used for the purchase of equipment,

payments of honoraria, alterations or

renovations, organizational dues,

entertainment or personal expenses,

cost of travel and payment of a Federal

employee, nor per diem or expenses

other than local mileage for local

participants.

• CDC and ATSDR funds may NOT

be used for reimbursement of indirect

costs.

• Although the practice of handing

out novelty items at meetings is often

employed in the private sector to

provide participants with souvenirs,

Federal funds CANNOT be used for this

purpose.

• CDC and ATSDR funds may be used

for only those parts of the conference

specifically supported by CDC as

documented in the grant award.

• CDC and ATSDR will NOT fund

100% of any conference proposed under

this announcement.

Purpose

The purpose of the CDC and ATSDR

conference support grants is to provide

PARTIAL support for specific nonFederal conferences in the areas of

health promotion and disease

prevention information/education

programs, (EXCEPT HIV INFECTION.)

CDC applications are being solicited

for conferences on: (1) Chronic disease

prevention; (2) Infectious disease

prevention; (3) Control of injury or

disease associated with environmental,

home, and work-place hazards; (4)

Environmental health; (5) Occupational

safety and health; (6) Control of risk

factors such as poor nutrition, smoking,

lack of exercise, high blood pressure,

and stress; (7) Health education and

promotion; (8) Laboratory practices; and

(9) Efforts that would strengthen the

public health system.

ATSDR applications are being

solicited for conferences on: (1) Health

effects of hazardous substances in the

environment; (2) Disease and toxic

substance exposure registries; (3)

Hazardous substance removal and